Daewoong Pharma (069620) — Net Asset Quality Index
Daewoong Pharma (069620) has a Net Asset Quality Index of 44.4% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩2.26 Trillion minus total liabilities of ₩1.26 Trillion yields net assets of ₩1.00 Trillion. A higher index indicates a stronger, lower-leverage balance sheet. Read 069620 total debt and obligations for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Daewoong Pharma Net Asset Quality Index Over Time (2007–2024)
This chart shows how Daewoong Pharma's Net Asset Quality Index has evolved across 16 annual periods from 2007 to 2024. As of September 2025, the index stands at 44.4%, representing net assets of ₩1.00 Trillion against total assets of ₩2.26 Trillion KRW. For live market cap and overall valuation, see Daewoong Pharma market capitalisation.
Annual Net Asset Quality Index for Daewoong Pharma (2007–2024)
The table below presents the year-by-year Net Asset Quality Index for Daewoong Pharma from 2007 to 2024, covering 16 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check Daewoong Pharma strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 46.9% | ₩926.98 Billion | ₩1.98 Trillion | ₩1.05 Trillion | ▼ -4.4 pp |
| 2023 | 51.3% | ₩802.97 Billion | ₩1.57 Trillion | ₩762.77 Billion | ▲ +3.9 pp |
| 2022 | 47.4% | ₩741.22 Billion | ₩1.56 Trillion | ₩822.12 Billion | ▼ -2.2 pp |
| 2021 | 49.6% | ₩702.41 Billion | ₩1.42 Trillion | ₩712.77 Billion | ▼ -1.2 pp |
| 2020 | 50.9% | ₩695.25 Billion | ₩1.37 Trillion | ₩671.66 Billion | ▼ -0.2 pp |
| 2019 | 51.1% | ₩635.92 Billion | ₩1.25 Trillion | ₩609.75 Billion | ▲ +0.7 pp |
| 2018 | 50.3% | ₩607.81 Billion | ₩1.21 Trillion | ₩600.04 Billion | ▼ -1.7 pp |
| 2017 | 52.0% | ₩631.54 Billion | ₩1.21 Trillion | ₩581.99 Billion | ▼ -0.8 pp |
| 2016 | 52.8% | ₩604.55 Billion | ₩1.14 Trillion | ₩540.15 Billion | ▼ -8.6 pp |
| 2015 | 61.4% | ₩580.24 Billion | ₩944.53 Billion | ₩364.29 Billion | ▼ -4.2 pp |
| 2014 | 65.6% | ₩455.51 Billion | ₩694.26 Billion | ₩238.76 Billion | ▼ -10.0 pp |
| 2013 | 75.6% | ₩437.96 Billion | ₩579.01 Billion | ₩141.05 Billion | ▼ -4.5 pp |
| 2012 | 80.1% | ₩386.59 Billion | ₩482.34 Billion | ₩95.76 Billion | ▲ +7.4 pp |
| 2011 | 72.7% | ₩362.42 Billion | ₩498.46 Billion | ₩136.04 Billion | ▲ +15.4 pp |
| 2008 | 57.3% | ₩278.85 Billion | ₩486.24 Billion | ₩207.39 Billion | ▼ -11.3 pp |
| 2007 | 68.6% | ₩269.57 Billion | ₩392.81 Billion | ₩123.24 Billion | — |